| |
|
|
|
Rigel Pharmaceuticals- Inc.  
|
|
2.62 -0.08 (-0.03%) |
08-17 16:00 |
|
Open: |
2.69 |
Pre close: |
2.7 |
Target:
|
3.50 
|
|
High: |
2.6901 |
Low: |
2.58 |
Resistance:
|
2.99
3.25
|
|
Volume: |
1,594,362 |
Market Cap: |
436M |
Support:
|
2.58
2.15
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.71
|
MACD |
MACD(12,26):
|
-0.08 |
|
MA(20): |
2.81 |
Signal(12,26,9): |
-0.08 |
|
MA(100): |
3.32 |
Stochastic Oscillator |
%K(14,3):
|
10.38 |
|
MA(250): |
3.51  |
%D(3): |
14.67 |
|
Average Volume(K) |
3-Month: |
232440
|
52-Week |
High:
|
4.71 |
|
10-Days: |
170580 |
Low: |
2.23 |
|
RSI |
RSI(14):
|
39.50 |
Change(%): |
17.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.650 |
Return on Equity (ttm) |
-96.8 |
Shares Out. (M) |
166.44 |
|
EPS Est. Current Year |
-0.600 |
Return on Assets (ttm) |
-82.5 |
Shares Float (M) |
166.14 |
|
EPS Est. Next Year |
-0.430 |
PEG Ratio |
-0.07 |
% Held by Insiders |
0.20 |
|
EPS Est. Next Quarter |
-0.150 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
84.20 |
|
Forward EPS |
-0.470 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
16588 |
|
Book Value (p.s.) |
3.760 |
EBITDA (p.s.) |
-0.107 |
P/E |
-4.03 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.70 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-80.19 |
P/S |
42857959424.00 |
|
Operating Margin |
-9794.22 |
Levered Free Cash Flow
(M) |
-47.78 |
P/CF |
-5.44 |
|
|
|
|
|
|
